---
title: "Timolol - Ocular hypertension - 3"
sidebar: mydoc_sidebar
permalink: db00484-mesh-d009798-3.html
toc: false 
---


Path ID: `DB00484_MESH_D009798_3`
{% include image.html url="images/db00484-mesh-d009798-3.png" file="db00484-mesh-d009798-3.png" alt="db00484-mesh-d009798-3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D013999 | timolol | Drug |
| UniProt:P08588 | Beta-1 adrenergic receptor | Protein |
| UniProt:P07550 | Beta-2 adrenergic receptor | Protein |
| REACT:R-HSA-418555 | G alpha (s) signalling events | Pathway |
| CHEBI:17489 | 3,5-cyclic AMP | ChemicalSubstance |
| UBERON:0001796 | aqueous humor of eyeball | GrossAnatomicalStructure |
| MESH:D009798 | Ocular hypertension | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Timolol | DECREASES ACTIVITY OF | Beta-2 Adrenergic Receptor |
| Timolol | DECREASES ACTIVITY OF | Beta-1 Adrenergic Receptor |
| Beta-2 Adrenergic Receptor | PARTICIPATES IN | G Alpha (S) Signalling Events |
| Beta-1 Adrenergic Receptor | PARTICIPATES IN | G Alpha (S) Signalling Events |
| G Alpha (S) Signalling Events | INCREASES ABUNDANCE OF | 3,5-Cyclic Amp |
| 3,5-Cyclic Amp | POSITIVELY CORRELATED WITH | Aqueous Humor Of Eyeball |
| Aqueous Humor Of Eyeball | POSITIVELY CORRELATED WITH | Ocular Hypertension |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00373#mechanism-of-action](https://go.drugbank.com/drugs/DB00373#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Timolol#Eye_drops](https://en.wikipedia.org/wiki/Timolol#Eye_drops)
  - [https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment](https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00373#mechanism-of-action](https://go.drugbank.com/drugs/DB00373#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Timolol#Eye_drops](https://en.wikipedia.org/wiki/Timolol#Eye_drops)
  - [https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment](https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00373#mechanism-of-action](https://go.drugbank.com/drugs/DB00373#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Timolol#Eye_drops](https://en.wikipedia.org/wiki/Timolol#Eye_drops)
  - [https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment](https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00373#mechanism-of-action](https://go.drugbank.com/drugs/DB00373#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Timolol#Eye_drops](https://en.wikipedia.org/wiki/Timolol#Eye_drops)
  - [https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment](https://en.wikipedia.org/wiki/Ocular_hypertension#Treatment)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342868/)
